Implementing chronic care for COPD: Planned visits, care coordination, and patient empowerment for improved outcomes

International Journal of COPD

Volumn 6, Issue 1, 2011, Pages 605-614

  Fromer, Len ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic care model; Chronic obstructive pulmonary disease; Coordination of care; Interdisciplinary care team; Patient centered medical home; Self management

Indexed keywords

AWARENESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; EDUCATION PROGRAM; FORCED EXPIRATORY VOLUME; HEALTH CARE PLANNING; HUMAN; MEDICAL INFORMATION; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT ATTITUDE; PATIENT EDUCATION; PROFESSIONAL COMPETENCE; PROFESSIONAL KNOWLEDGE; PUBLIC-PRIVATE PARTNERSHIP; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SPIROMETRY; TEAMWORK; TOTAL QUALITY MANAGEMENT; BEHAVIOR; DISEASE MANAGEMENT; LUNG FUNCTION TEST; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PATIENT PARTICIPATION; PRACTICE GUIDELINE; PRIMARY HEALTH CARE;

CONTINUITY OF PATIENT CARE; DISEASE MANAGEMENT; HUMANS; PATIENT CARE TEAM; PATIENT PARTICIPATION; PATIENT-CENTERED CARE; POWER (PSYCHOLOGY); PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS;

EID: 84856095448     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S24692     Document Type: Review

References (65)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD. Dec 2010. Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html. Accessed July 25, 2011.
2. American Thoracic Society, European Respiratory Society. Standards for the diagnosis and management of patients with COPD. 2004. Available from: http://www.thoracic.org/clinical/copd-guidelines/. Accessed October 25, 2011.
3. Bodenheimer T. Planned visits to help patients self-manage chronic conditions. Am Fam Physician. 2005;72(8):1454, 1456.
4. Bastin AJ, Starling L, Ahmed R, et al. High prevalence of undiagnosed and severe chronic obstructive pulmonary disease at first hospital admission with acute exacerbation. Chron Respir Dis. 2010;7(2): 91-97.
5. Zoia MC, Corsico AG, Beccaria M, et al. Exacerbations as a starting point of pro-active chronic obstructive pulmonary disease management. Respir Med. 2005;99(12):1568-1575.
6. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847-852.
7. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1418-1422.
8. McGhan R, Radcliff T, Fish R, Sutherland ER, Welsh C, Make B. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest. 2007;132(6):1748-1755.
9. Halpern MT, Stanford RH, Borker R. The burden of COPD in the USA: results from the Confronting COPD survey. Respir Med. 2003; 97 Suppl C:S81-S89.
10. Anzueto A. Primary care management of chronic obstructive pulmonary disease to reduce exacerbations and their consequences. Am J Med Sci. 2010;340(4):309-318.
11. Bindman AB, Chattopadhyay A, Auerback GM. Interruptions in Med-icaid coverage and risk for hospitalization for ambulatory care-sensitive conditions. Ann Intern Med. 2008;149(12):854-860.
12. ZuWallack R. How are you doing? What are you doing? Differing perspectives in the assessment of individuals with COPD. COPD. 2007;4(3):293-297.
13. Martinez FJ, Raczek AE, Seifer FD, et al. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD. 2008;5(2):85-95.
14. Yawn B P, Mapel DW, Mannino DM, Martinez FJ, Dalal AA. Performance of a brief, self-administered questionnaire (Lung Function Questionnaire) to identify patients at risk of airfow obstruction as potential candidates for spirometry: scoring and cut point. Am J Respir Crit Care Med. 2009;179:A1476.
15. Yawn B P, Enright PL, Lemanske Jr RF, et al. Spirometry can be done in family physicians' offces and alters clinical decisions in management of asthma and COPD. Chest. 2007;132(4):1162-1168.
16. Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract. 1998;1(1):2-4.
17. American Academy of Family Physicians. Joint principles of the patient-centered medical home. Del Med J. 2008;80(1):21-22.
18. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002;288(14):1775-1779.
19. Rittenhouse DR, Shortell SM, Fisher ES. Primary care and accountable care - two essential elements of delivery-system reform. N Engl J Med. 2009;361(24):2301-2303.
20. Fisher ES, McClellan MB, Bertko J, et al. Fostering accountable health care: moving forward in Medicare. Health Aff (Millwood). 2009;28(2):w219-w231.
21. Bein B. AMA delegates adopt AAFP's joint principles of patient-centered medical home. Ann Fam Med. 2009;7(1):86-87.
22. American College of Physicians. The Patient-Centered Medical Home Neighbor. The Interface of the Patient-Centered Medical Home with Specialty/Subspecialty Practices. Policy paper. Philadelphia, PA: American College of Physicians; 2010.
23. Adams SG, Smith PK, Allan PF, Anzueto A, Pugh JA, Cornell JE. Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Arch Intern Med. 2007;167(6):551-561.
24. Coleman K, Mattke S, Perrault PJ, Wagner EH. Untangling practice redesign from disease management: how do we best care for the chronically ill? Annu Rev Public Health. 2009;30:385-408.
25. Moore LG. Escaping the tyranny of the urgent by delivering planned care. Fam Pract Manag. 2006;13(5):37-40.
26. Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3): 179-191.
27. ® prescribing information. Jun 2010. Available from: http://bidocs.boehringer-ingelheim.com/ BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=/ Prescribing+Information/PIs/Spiriva/Spiriva.pdf. Accessed February 17, 2011.
28. GlaxoSmithKline. Advair Diskus prescribing information. Jun 2010. Available from: http://us.gsk.com/products/assets/us_advair.pdf. Accessed February 17, 2011.
29. Novartis. Arcapta™ Neohaler™ prescribing information. Jul 2011. Available from: http://www.pharma.us.novartis.com/product/pi/pdf/arcapta.pdf. Accessed August 25, 2011.
30. Moore LG. Creating a high-performing clinical team. Fam Pract Manag. 2006;13(3):38-40.
31. Hart MK, Millard M W. Approaches to chronic disease management for asthma and chronic obstructive pulmonary disease: strategies through the continuum of care. Proc (Bayl Univ Med Cent). 2010;23(3): 223-229.
32. Dodds S, Chamberlain C, Williamson GR. Modernising chronic obstructive pulmonary disease admissions to improve patient care: local outcomes from implementing the Ideal Design of Emergency Access project. Accid Emerg Nurs. 2006;14(3):141-147.
33. Nutting PA, Miller WL, Crabtree B F, Jaen CR, Stewart EE, Stange KC. Initial lessons from the frst national demonstration project on practice transformation to a patient-centered medical home. Ann Fam Med. 2009;7(3):254-260.
34. Heffner JE, Mularski RA, Calverley PM. COPD performance measures: missing opportunities for improving care. Chest. 2010;137(5): 1181-1189.
35. Hofer T P, Zemencuk JK, Hayward RA. When there is too much to do: how practicing physicians prioritize among recommended interventions. J Gen Intern Med. 2004;19(6):646-653.
36. Reid RJ, Fishman PA, Yu O, et al. Patient-centered medical home demonstration: a prospective, quasi-experimental, before and after evaluation. Am J Manag Care. 2009;15(9):e71-e87.
37. Rice KL, Dewan N, Bloomfeld HE, et al. Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med. 2010;182(7):890-896.
38. Bourbeau J, Julien M, Maltais F, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med. 2003;163(5):585-591.
39. Koff PB, Jones RH, Cashman JM, Voelkel N F, Vandivier RW. Proactive integrated care improves quality of life in patients with COPD. Eur Respir J. 2009;33(5):1031-1038.
40. McLean S, Nurmatov U, Liu JL, Pagliari C, Car J, Sheikh A. Telehealthcare for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011;7:CD007718.
41. Takigawa N, Tada A, Soda R, et al. Comprehensive pulmonary rehabilitation according to severity of COPD. Respir Med. 2007;101(2): 326-332.
42. Maltais F, Bourbeau J, Shapiro S, et al. Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med. 2008;149(12):869-878.
43. Casaburi R, Kukafka D, Cooper CB, Witek TJ Jr, Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest. 2005;127(3):809-817.
44. O'Donnell DE, Voduc N, Fitzpatrick M, Webb KA. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J. 2004;24(1):86-94.
45. Neder JA, Fuld J P, Overend T, et al. Effects of formoterol on exercise tolerance in severely disabled patients with COPD. Respir Med. 2007;101(10):2056-2064.
46. Worth H, Forster K, Eriksson G, Nihlen U, Peterson S, Magnussen H. Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD. Respir Med. 2010;104(10):1450-1459.
47. O'Donnell DE, Sciurba F, Celli B, et al. Effect of futicasone propionate/ salmeterol on lung hyperinfation and exercise endurance in COPD. Chest. 2006;130(3):647-656.
48. Pasqua F, Biscione G, Crigna G, Auciello L, Cazzola M. Combining triple therapy and pulmonary rehabilitation in patients with advanced COPD: a pilot study. Respir Med. 2010;104(3):412-417.
49. Kesten S, Casaburi R, Kukafka D, Cooper CB. Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients. Int J Chron Obstruct Pulmon Dis. 2008;3(1):127-136.
50. Weiss M, Britten N. What is concordance? Pharm J. 2003; 271(7270):493.
51. Post L, Collins C. The poorly coping COPD patient: a psychotherapeutic perspective. Int J Psychiatry Med. 1981;11(2):173-182.
52. Alexopoulos GS, Raue PJ, Sirey JA, Arean PA. Developing an intervention for depressed, chronically medically ill elders: a model from COPD. Int J Geriatr Psychiatry. 2008;23(5):447-453.
53. Kotz D, Huibers MJ, West RJ, Wesseling G, van Schayck OC. What mediates the effect of confrontational counselling on smoking cessation in smokers with COPD? Patient Educ Couns. 2009;76(1):16-24.
54. Toljamo T, Kaukonen M, Nieminen P, Kinnula VL. Early detection of COPD combined with individualized counselling for smoking cessation: a two-year prospective study. Scand J Prim Health Care. 2010;28(1):41-46.
55. Wilhelm K, Arnold K, Niven H, Richmond R. Grey lungs and blue moods: smoking cessation in the context of lifetime depression history. Aust N Z J Psychiatry. 2004;38(11-12):896-905.
56. Robinson A, Courtney-Pratt H, Lea E, et al. Transforming clinical practice amongst community nurses: mentoring for COPD patient self-management. J Clin Nurs. 2008;17:370-379.
57. Klok T, Sulkers EJ, Kaptein AA, Duiverman EJ, Brand PL. Adherence in the case of chronic diseases: patient-centred approach is needed. Ned Tijdschr Geneeskd. 2009;153:A420. Dutch.
58. Nathan A, Goodyer L, Lovejoy A, Rashid A. "Brown bag" medication reviews as a means of optimizing patients' use of medication and of identifying potential clinical problems. Fam Pract. 1999;16(3):278-282.
59. Melani AS, Bonavia M, Cilenti V, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105(6):930-938.
60. Melani AS. Inhalatory therapy training: a priority challenge for the physician. Acta Biomed. 2007;78(3):233-245.
61. George J, Kong DC, Stewart K. Adherence to disease management programs in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2007;2(3):253-262.
62. ®-Patient-Centered Medical Home (PPC-PCMH™). Washington, DC: National Committee for Quality Assurance; 2008.
63. Boyd CM, Reider L, Frey K, et al. The effects of guided care on 65. the perceived quality of health care for multi-morbid older persons: 18-month outcomes from a cluster-randomized controlled trial. J Gen Intern Med. 2010;25(3):235-242.
64. Garcia-Aymerich J, Hernandez C, Alonso A, et al. Effects of an integrated care intervention on risk factors of COPD readmission. Respir Med. 2007;101(7):1462-1469.
65. Drescher GS, Carnathan BJ, Imus S, Colice GL. Incorporating tiotropium into a respiratory therapist-directed bronchodilator protocol for managing in-patients with COPD exacerbations decreases bronchodilator costs. Respir Care. 2008;53(12):1678-1684.